Capricor Therapeutics Inc (NASDAQ: CAPR) stock closed at $17.31 on 10/9/24 after a major decline of -10.5%. This decline was accompanied by normal trading volume. The stock has risen 15.3% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CAPR is expected to continue to be Value Creation neutral.
Capricor Therapeutics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Capricor Therapeutics has a very low Appreciation Score of 1 but a slightly positive Power Rating of 69, with the Negative Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment